Anthropic Delays Potential $2 Trillion IPO Amid AI Safety Concerns

Anthropic, a prominent artificial intelligence company, is reportedly postponing its initial public offering (IPO), which could be valued at up to $2 trillion. The delay, with a potential new target of November, comes amid growing concerns about the rapid advancement of AI technology and its potential risks.

Previously, Anthropic had been expected to pursue a stock market listing as early as October. However, sources familiar with the plans indicate that the timeline is flexible and could be extended further, possibly beyond the U.S. midterm elections. This potential delay reflects a broader industry debate and internal reflections on the pace of AI development.

The concerns are amplified by warnings from individuals within the AI industry, including former Anthropic researcher Jacob Coxon. Coxon recently resigned, issuing a stark warning that companies like Anthropic and OpenAI are progressing too rapidly toward increasingly powerful AI systems. His comments, which gained significant online traction, highlight fears that AI development might be outpacing the implementation of necessary safety measures. Coxon has articulated concerns that advanced AI could pose an existential threat to humanity if systems become too autonomous to control.

Interestingly, Anthropic's chief executive, Dario Amodei, has himself advocated for a slowdown in the development of advanced AI models. Amodei has called for the industry to deliberately reduce the pace of improvement for its most sophisticated systems to allow safety protocols to advance. He has also emphasized the need for independent evaluators, standardized safety benchmarks, and international collaboration.

These internal and external calls for caution come as Anthropic has reported blocking several attempts this year to use its AI systems for research that could potentially lead to the development of biological weapons. While the company could not determine the exact intent of these users, the incidents underscore the potential for AI misuse.

President Donald Trump has publicly rejected calls for a slowdown, asserting that his leadership can ensure AI safety and warning against what he termed a "sick conspiracy" related to China's AI development. He stated on Truth Social that "The only control or 'guardrails' that AI needs is a strong and smart (High IQ!) president, and the U.S.A. has that, in spades!"

Anthropic co-founder Jack Clark has also voiced strong opinions on the matter, advocating for common safety standards and external scrutiny within the AI industry. He has noted that the sector has already encountered "warning shots" from AI systems exhibiting unexpected behaviors, suggesting a critical window to address risks before they escalate.

The potential IPO is significant, with Anthropic reportedly discussing a valuation of around $2 trillion and a fundraising target of up to $100 billion. This would represent a substantial increase from its previous private valuation of approximately $965 billion following a major funding round earlier this year. The company's rapid growth, with annualized revenue reportedly exceeding $65 billion by July, has contributed to investor interest.

However, Anthropic faces increasing competition, notably from OpenAI's GPT-6 Astra model. Data suggests Astra is capturing a significant portion of enterprise AI spending, prompting questions about Anthropic's market position. Despite this, Anthropic maintains a higher reported annualized revenue run rate compared to OpenAI.

The company is exploring strategies to maintain its momentum, including potentially releasing another AI model before its IPO, though safety considerations are part of this decision-making process. Anthropic's financial picture is also bolstered by significant partnerships with technology giants like Amazon and Google. Beyond its well-known chatbot Claude, Anthropic is expanding into new areas, including establishing a biology laboratory focused on drug science, indicating a search for lucrative applications beyond traditional AI services.

The forthcoming IPO, should it proceed, will serve as a key test of Wall Street's appetite for the booming AI sector and its willingness to invest heavily in companies operating at the forefront of this rapidly evolving technology.